EPI-ZOSTER-044: Effectiveness and safety of recombinant zoster vaccine in patients with rheumatoid arthritis (RA) or inflammatory bowel disease (IBD)
The purpose of the study is to evaluate the safety and effectiveness of recombinant herpes zoster vaccine (RZV) in adults>=18 years of age with rheumatoid arthritis or inflammatory bowel disease (ulcerative colitis or Crohn’s disease).